Exosomes: the new frontier of cell regeneration

[INDICE:h2]

For years, advanced skincare has revolved around a few key ingredients: hyaluronic acid, vitamin C, retinol, and peptides. Today, one word is appearing more and more often, both in aesthetic medicine protocols and in high-tech serums: exosomes. They’re mentioned alongside treatments for enlarged pores, dark spots, fine lines, and dull skin, often with promises of total skin regeneration. But what are they really, and what does the scientific evidence say, as opposed to the marketing?

First, the short answer: exosomes are not an active ingredient comparable to niacinamide or retinol. The same term refers to biologically very different materials, most studies focus on medical procedures rather than creams, and human-derived exosomes are not even permitted in cosmetics in Europe.

What are exosomes?

Exosomes are extracellular vesicles produced by the body that transfer information between cells: micro-RNAs, growth factors, proteins, and lipids. Cells release them into their surroundings to communicate with each other, like biological nanopackages that carry messages.

The vesicles we now call exosomes were observed in the early 1980s during studies of reticulocyte maturation. Reticulocytes are precursors to red blood cells. At first, they seemed to be a system the cell used to get rid of material it no longer needed. Only later did scientists discover that they also play a role in communication between cells. This is where interest in regenerative medicine began, and subsequently in aesthetic dermatology.

In the skin, this means they can influence key processes: collagen and elastin production, inflammatory response, tissue repair, and the management of oxidative stress and pigmentation.

You often hear about “stem cell exosomes,” which is where the confusion starts. Stem cells are one of the main sources of exosomes. In recent years, many researchers have shifted their focus from using stem cells directly to using their vesicles, because this makes it possible to harness some of their regenerative potential while reducing the risks associated with cell manipulation.

Where exosomes are found

In the body, practically everywhere. Almost all cells release them, and they are found in bodily fluids: blood, saliva, urine, and breast milk. In the skin, too, keratinocytes, fibroblasts, and melanocytes use them to exchange signals, for example in regulating pigment and responding to injury.

In the beauty world, however, exosomes come from three sources: laboratory cell cultures, which are used to obtain preparations for aesthetic medicine, often combined with microneedling or laser treatments; plant extracts; fermentation processes. Cosmetics sold in Europe contain only the latter two, or technologies that mimic their structure: those of human origin are not permitted, as we’ll see later.

Exosome or extracellular vesicle? The distinction rarely made

The scientific community itself urges caution when it comes to terminology. The MISEV2023 guidelines from the International Society for Extracellular Vesicles recommend using the general term “extracellular vesicles” when the cellular origin and the pathway by which the vesicle formed have not been precisely established.

“Exosome” refers to a specific subpopulation, produced through a particular pathway within the cell. Proving this requires characterization and controls that cannot be taken for granted. In cosmetics, however, the term is used as an umbrella for vesicles, extracts, delivery systems, or technologies that mimic their function.

This flexibility does not mean the product is ineffective. It means that you cannot infer either the composition or the activity from the name. The same distinction applies to any ingredient: what matters is what’s in the formula, not what it’s called on the label.

Human, plant, bacterial, or “inspired”: they are not the same thing

Origin is the first piece of information that should accompany every product, and it changes everything.

Vesicles of human origin

Most studies in aesthetic dermatology use vesicles obtained from mesenchymal cell cultures (adipose tissue, umbilical cord) or from platelets. These are biologically complex materials whose composition also depends on culture conditions, and they raise questions about microbiological control, purity, contaminants, and reproducibility.

They are also, as we will see, not permitted for use in a European cosmetic product.

Vesicles of plant origin

These are the ones most commonly found in cosmetics: particles similar to extracellular vesicles obtained from fruit, leaves, and roots. They are interesting both for their potential to transport bioactive substances and for their compatibility with a plant-based, biotechnological positioning.

Calling them "plant exosomes" is intuitive but not entirely accurate: plants have structures and formation pathways that do not match those of animal cells. Much of the data concerns cell or animal models, and there are still few clinical studies on the finished cosmetic product.

There is also a practical problem: plant microvesicles are fragile and often do not withstand heat, time, and packaging well.

Bacterial or fermentation-derived vesicles

Bacteria and microorganisms also release vesicles. Fermentation makes it possible to produce them in a more controlled and scalable way, but claiming a biotechnological origin does not prove a benefit: the species used, culture conditions, purification, and safety profile remain decisive.

Exosome-like or exosome-inspired technologies

Some formulas do not contain isolated biological vesicles, but lipid systems designed to imitate a transport function. These may be valid technologies, but they should be described for what they are. A liposome does not become an exosome just because it resembles one in size.

What effects have been observed

Reviews published in recent years describe encouraging results for wrinkles, elasticity, hydration, pigmentation, acne scars, and recovery after procedures. A 2026 systematic review on skin rejuvenation included 21 studies and found consistent signs of a possible increase in collagen and elastin and a reduction in oxidative stress.

At the mechanistic level, studies have shown that different types of vesicles (often derived from mesenchymal stem cells or fibroblasts) can:

• stimulate the synthesis of collagen I and III and elastin;
• reduce the activity of matrix metalloproteinases (MMPs), which are responsible for the degradation of the extracellular matrix;
• improve hydration and barrier function;
• modulate hyperpigmentation by supporting cell turnover and influencing melanocytes and keratinocytes.

The point that changes everything: those studies aren’t about a cream

This is the key point to understand, and it’s often missing from the marketing. A significant number of studies combine the vesicles with fractional laser, microneedling, or radiofrequency microneedling. These procedures create microchannels or temporarily alter the barrier, making it easier for the product to penetrate, and they also trigger a skin response on their own.

A specific example. In a 2020 randomized split-face study of twenty-five people with acne scars, the entire face was treated with a fractional CO₂ laser; then one side received a gel containing adipose-derived exosomes and the other a control gel. The side treated with exosomes improved more. This is an interesting result, but it tells us just one thing: that on skin already microperforated by the laser, that gel works better than the control. It says nothing about a cream applied to intact skin.

The same applies to a twelve-week randomized prospective study of adipose-derived vesicles used alongside microneedling for facial aging: the results were positive, but the effects of the procedure and the biological material can’t be separated, nor can they be extrapolated to at-home use.

Many studies also involve only a few dozen participants, have short follow-up periods, and use preparations that differ in origin, concentration, and characterization. There are no shared standards: there’s no way to truly compare “one billion vesicles” in one product with the same stated number in another. Even the more favorable reviews call for larger studies and standardized methods. This isn’t a rejection: it’s simply where a young field stands.

The picture is even less clear for cosmetics applied at home. A scoping review published in 2026 in the Aesthetic Surgery Journal looked specifically at topical exosomes: there are still few studies in humans, and products on the market provide minimal information about their origin, isolation method, and shelf life. That's why you'll find five questions further on.

The skin barrier is the real testing ground

The skin is designed to limit the entry of external substances. Vesicles are nanoscale, but small size does not mean effective penetration: the ability to reach the vital layers depends on composition, surface charge, vehicle, barrier integrity, and stability in the product.

Then there are the practical questions that formulators need to ask themselves. Do the vesicles survive production? Do they remain intact throughout the shelf life? Can they withstand preservatives, temperature fluctuations, and contact with other ingredients? Do they retain the same biological cargo from one batch to the next?

Finally, there's an effect that causes a lot of confusion: a formula may hydrate very well thanks to glycerin, hyaluronic acid, niacinamide or beta-glucans found alongside the innovative technology. L's positive experience doesn't tell us which component produced the result.

The regulatory point: in Europe, human origin changes everything

This is the information missing from many discussions on the subject, and it settles the matter better than any debate about efficacy.

Regulation (EC) 1223/2009 prohibits the use of “cells, tissues or products of human origin” in cosmetics under entry 416 of Annex II. Therefore, exosomes or derivatives that are genuinely human are not permitted ingredients in a cosmetic sold in the European Union. If a product sold in Europe promises human exosomes, either it does not contain them or it is not a compliant cosmetic.

Plant-, microbial- or synthetic-origin vesicles are not subject to an equivalent ban, but they must still meet all other requirements: safety assessment of the finished product, product information file, good manufacturing practices, notification, and claims supported by evidence.

In the United States, the boundary also depends on the intended use. The FDA has reiterated that no exosome-based products have been approved as regenerative therapies, and in May 2026 renewed its warning about unapproved products derived from human cells or tissues: a reminder that primarily concerns preparations marketed to treat diseases, not every plant-based cosmetic.

The decisive word remains claim. Promising hydration or an improvement in the skin's appearance falls within the realm of cosmetics; claiming tissue regeneration, healing, or treatment of a disease moves the product into the realm of medicines. This is a regulatory difference, not a matter of nuance in wording.

Five Questions to Ask About a Cosmetic That Claims to Contain Exosomes

The first question is not "how many billion does it contain?" but "what exactly does it contain?"

1. What is the stated origin? Plant-based, bacterial, synthetic, and human-derived are not interchangeable. Vague terms like "bioidentical" or "cell-derived" do not make it possible to understand the source or confirm compliance.
2. Are these characterized vesicles or an inspired technology? A transparent company says whether it uses isolated vesicles, lysates, liposomes, or a biomimetic system. These are all legitimate approaches, but they are different.
3. Is there a study on the finished product? An in vitro test on a raw ingredient demonstrates a possible mechanism. To support a claim about the serum, data are needed on the formula actually being sold, including the amount, frequency and duration of use, and the parameters measured.
4. Was the test performed on intact skin? Results obtained after laser treatment or microneedling do not describe at-home use.
5. Are stability and storage documented? A vesicle that degrades in the bottle cannot do what it did in the lab. Packaging, temperature, and shelf life are not minor details.

From Theory to Practice: A Rejuvenating Routine

The truly advanced approach is not chasing the latest trend, but combining active ingredients backed by robust research with newer technologies when appropriate, without turning the latter into miraculous promises. LeLang focuses on formulas supported by evidence and free of excessive claims: niacinamide for pores and sebum, enhanced vitamin C for radiance, peptides for firmness.

Radiance and Even Tone

For radiance and mild discoloration, FeruliC + HA Serum combines ferulic acid and vitamin C with hyaluronic acid. L'ferulic acid stabilizes vitamin C, which supports an even skin tone and collagen synthesis. Suitable for dull or photoaged skin.

Dynamic wrinkles and firmness

For fine lines and skin tone, the serum with Botoxil technology uses relaxing peptides such as argireline to soften expression lines and support the skin matrix. Gradual results in elasticity and firmness, consistent with the literature on peptides.

Enlarged pores and texture

Cleansing Active Mousse from the Acnerebal line contains 0.5% salicylic acid, tea tree, burdock, and betaine. Unclogs pores, smooths the skin's surface, and controls sebum without over-drying.

The treatment is completed by Acnerebal Serum, which helps reduce the appearance of enlarged pores, and Acnerebal Cream, with its soothing action. The complete protocol is in the guide to a skincare routine for oily skin and enlarged pores.

Conclusion: promising, but the name alone is not enough

Exosomes are not a social media invention: they emerged from more than forty years of research into cellular communication and have real potential in regenerative medicine. The first clinical studies on skin are interesting, especially as an adjunct to professional procedures.

Daily skincare, however, is a different matter. The origin of the vesicles, their ability to cross the skin barrier, their stability in a formula, and reproducibility remain points to be demonstrated for each product. And under the same label, biological, plant-based, microbial, and simply exosome-inspired systems coexist.

The right question is not whether exosomes work in general. It is: which vesicles, in what formulation, applied how, and measured in which study?

In the meantime, ingredients such as niacinamide, hyaluronic acid, and vitamin C, when used consistently and thoughtfully, remain highly effective for improving the appearance of the skin in many situations. Consistency is key, along with choosing companies that are transparent about their evidence. You can also find LeLang products at partner pharmacies in your area, where someone can help you read a label before you buy.

Sources for this article

01 Welsh J.A. et al., Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches, Journal of Extracellular Vesicles, 2024; 13(2): e12404.
02 Kwon H.H. et al., Combination treatment with human adipose tissue stem cell-derived exosomes and fractional CO₂ laser for acne scars: a 12-week prospective, double-blind, randomized, split-face study, Acta Dermato-Venereologica, 2020; 100(18).
03 Park G.H. et al., randomized prospective study on microneedling and extracellular vesicles for facial aging, 2023 (PubMed, PMID 37377400).
04 Systematic review on the efficacy of exosome-based therapies for skin rejuvenation, 2026, twenty-one studies included.
05 Regulation (EC) No. 1223/2009 on cosmetic products, Annex II, entry 416.
06 FDA, consumer alert about unapproved products derived from human cells or tissues, May 11, 2026.
07 Scoping review, Clinical Evidence and Commercial Landscape of Topical Exosomes for Skin Rejuvenation, Aesthetic Surgery Journal, 2026.

On the site: peptides in cosmetics · skin barrier · hyaluronic acid · anti-aging collection